全文获取类型
收费全文 | 3677篇 |
免费 | 236篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 89篇 |
妇产科学 | 106篇 |
基础医学 | 505篇 |
口腔科学 | 68篇 |
临床医学 | 421篇 |
内科学 | 1032篇 |
皮肤病学 | 49篇 |
神经病学 | 188篇 |
特种医学 | 297篇 |
外科学 | 548篇 |
综合类 | 36篇 |
预防医学 | 177篇 |
眼科学 | 53篇 |
药学 | 196篇 |
中国医学 | 1篇 |
肿瘤学 | 177篇 |
出版年
2021年 | 37篇 |
2020年 | 33篇 |
2019年 | 49篇 |
2018年 | 78篇 |
2017年 | 42篇 |
2016年 | 59篇 |
2015年 | 69篇 |
2014年 | 63篇 |
2013年 | 131篇 |
2012年 | 142篇 |
2011年 | 161篇 |
2010年 | 90篇 |
2009年 | 93篇 |
2008年 | 153篇 |
2007年 | 175篇 |
2006年 | 147篇 |
2005年 | 118篇 |
2004年 | 128篇 |
2003年 | 117篇 |
2002年 | 115篇 |
2001年 | 106篇 |
2000年 | 137篇 |
1999年 | 124篇 |
1998年 | 61篇 |
1997年 | 57篇 |
1996年 | 63篇 |
1995年 | 55篇 |
1994年 | 49篇 |
1993年 | 51篇 |
1992年 | 92篇 |
1991年 | 80篇 |
1990年 | 95篇 |
1989年 | 97篇 |
1988年 | 92篇 |
1987年 | 83篇 |
1986年 | 79篇 |
1985年 | 60篇 |
1984年 | 59篇 |
1983年 | 56篇 |
1982年 | 33篇 |
1981年 | 39篇 |
1980年 | 29篇 |
1979年 | 36篇 |
1978年 | 28篇 |
1977年 | 36篇 |
1976年 | 30篇 |
1975年 | 34篇 |
1974年 | 36篇 |
1973年 | 34篇 |
1970年 | 20篇 |
排序方式: 共有3963条查询结果,搜索用时 15 毫秒
1.
In recent years, there has been an increased focus on patient involvement in treatment planning in the health care system. To reduce the risk of the clinician moving towards paternalism, various methods have been introduced—shared decision making, among others. The goal of shared decision making is for the clinician and patient to share available evidence on the best treatment and to raise awareness on the needs and preferences of the patient as to make a genuinely informed choice. However, in the present article, we discuss to which degree paternalism can be avoided in light of the clinician's role as an authority with certain knowledge and expertise. Through the philosophical theory of reasons‐responsiveness, we discuss to which extend free will and control applies to the patient. Through theoretical analysis, we come to suggest that the clinician has a role as an ally rather than manipulator. 相似文献
2.
Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized,placebo‐controlled FDG‐PET study
下载免费PDF全文
![点击此处可从《Clinical endocrinology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
3.
K Thomsen B J Riis J S Johansen C Christiansen P R?dbro 《Gynecological endocrinology》1987,1(2):169-175
Bone turnover before and after withdrawal of estrogen/gestagen treatment was studied in a randomized trial with 110 healthy female volunteers, who had passed a natural menopause 6 months to 3 years before the start of the study. Urinary excretion of intravenously injected 99m-technetium diphosphonate was measured as an index of bone turnover; plasma bone Gla protein and serum alkaline phosphatase were measured as indices of bone formation; and fasting urinary excretion of hydroxyproline and calcium were measured as estimates of bone resorption. During 2 years of hormone treatment, all variables decreased highly significantly (p less than 0.001) to a constant low level. Three months after withdrawal all variables increased highly significantly (p less than 0.001) towards, but not above, pretreatment and placebo levels. We conclude that withdrawal of estrogen/gestagen replacement therapy in postmenopausal women increases bone turnover, but not in excess of pretreatment values. This indicates that bone loss (after withdrawal) is similar to that seen in the placebo group and that a rebound phenomenon is unlikely. 相似文献
4.
5.
Jens O L J?rgensen Louise M?ller Morten Krag Nils Billestrup Jens S Christiansen 《Endocrinology & Metabolism Clinics of North America》2007,36(1):75-87
This article focuses on in vivo data from tests performed in normal subjects and in patients who had abnormal growth hormone (GH) status. Experimental data in human subjects demonstrate that GH acutely inhibits glucose disposal in skeletal muscle. At the same time GH stimulates the turnover and oxidation of free fatty acid (FFA), and experimental evidence suggests a causal link between elevated FFA levels and insulin resistance in skeletal muscle. Observational data in GH-deficient adults do not indicate that GH replacement is associated with significant impairment of glucose tolerance, but it is recommended that overdosing be avoided and glycemic control be monitored. 相似文献
6.
PURPOSE: Currently, no drug treatment is available for strengthening underacting extraocular muscles (EOM) in strabismus. We showed previously that single injections of insulin-like growth factor (IGF-1) result in significant but short-term increases in muscle force generation. This study examined the effects of sustained release of IGF-1 on force generation in rabbit superior rectus muscles. METHODS: In adult rabbits, slow-release pellets containing IGF-1 were implanted on the global side of one superior rectus muscle. After 1 week, or 1, 2, 3, or 6 months, treated and control muscles were examined for force generation using an in vitro physiology apparatus. All muscles were prepared for histology and mean myofiber cross-sectional areas were determined. RESULTS: One and 3 months after pellet implantation, treated muscles generated significantly greater force than contralateral control muscles, whereas at 2 months, no significant difference was found. Force per cross-sectional area (mN/cm(2)) at 3 months also increased significantly in the treated muscles. Mean muscle cross-sectional area increased significantly after 1, 2, and 3 months of sustained exposure to IGF-1 compared with controls. After an additional 3 months without IGF-1 exposure, mean cross-sectional areas were significantly greater than controls but significantly reduced compared with areas at 1, 2, and 3 months. CONCLUSIONS: IGF-1 appears to be highly effective in increasing muscle force generation. Because slow release of IGF-1 results in sustained increases in EOM force generation, it may be a potentially useful alternative to surgical resection procedures because it avoids many of the potential long-term biomechanical hazards of resection surgery. 相似文献
7.
8.
9.
10.